A Study to Investigate a New Oxygen Delivery Device while Walking

Not Applicable

Completed

• Conditions: Chronic obstructive pulmonary disease (COPD); Other chronic respiratory disease (e.g. bronchiectasis and interstitial lung disease); Respiratory - Chronic obstructive pulmonary disease; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12618001144202
• Lead Sponsor: Fisher and Paykel Healtcare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-12
• Study Completion: 2019-07-02
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

• Doctor’s diagnosis of chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD), interstitial lung disease or bronchiectasis
• Age >18 years
• SpO2 <90% during 6 minute walk test, demonstrated at visit one.
• Stable respiratory state with no exacerbation in last 4 weeks

Exclusion Criteria

• Requirement for long term oxygen therapy (LTOT) or SpO2 <92% at rest
• Presence of any absolute or relative (at investigator discretion) contraindications to 6 minute walk test as per ATS/ERS technical standard
• Diagnosis of a notifiable disease
• Infection or colonization with multidrug resistant bacteria, Pseudomonas species, Burkholderia Cepacia or mycobacteria
• The presence of an implantable Medical Device
• Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

Study & Design

• Study Type: Interventional
• Study Design: Not specified